^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
HY004
i
Other names: HY004, HY 004, Anti-CD19-anti-CD22 CAR-T cell therapy, autologous CD19-CD22 CAR-T cells, HY-004
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Juventas Cell Therapy
Drug class:
CD19-targeted CAR-T immunotherapy, CD22-targeted CAR-T immunotherapy
Related drugs:
